As of 2025-05-23, the Intrinsic Value of Nova Leap Health Corp (NLH.V) is 0.24 CAD. This NLH.V valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.25 CAD, the upside of Nova Leap Health Corp is -2.50%.
The range of the Intrinsic Value is 0.17 - 0.44 CAD
Based on its market price of 0.25 CAD and our intrinsic valuation, Nova Leap Health Corp (NLH.V) is overvalued by 2.50%.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 0.17 - 0.44 | 0.24 | -2.5% |
DCF (Growth 10y) | 0.21 - 0.53 | 0.30 | 20.9% |
DCF (EBITDA 5y) | 0.21 - 0.30 | 0.26 | 5.8% |
DCF (EBITDA 10y) | 0.24 - 0.36 | 0.31 | 22.6% |
Fair Value | 0.55 - 0.55 | 0.55 | 120.51% |
P/E | 0.15 - 0.23 | 0.19 | -24.0% |
EV/EBITDA | 0.09 - 0.22 | 0.15 | -38.4% |
EPV | 0.25 - 0.39 | 0.32 | 28.4% |
DDM - Stable | 0.17 - 0.54 | 0.35 | 41.0% |
DDM - Multi | 0.29 - 0.76 | 0.43 | 71.5% |
Market Cap (mil) | 21.83 |
Beta | -0.01 |
Outstanding shares (mil) | 87.31 |
Enterprise Value (mil) | 23.40 |
Market risk premium | 5.10% |
Cost of Equity | 8.42% |
Cost of Debt | 4.28% |
WACC | 7.66% |